WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) General Information

Description

Preclinical trispecific T-cell engager in Wuxi, China.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Wuxi, Jiangsu
  • China
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Corporate Office
  • Wuxi, Jiangsu
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China)‘s full profile, request access.

Request a free trial

WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China)‘s full profile, request access.

Request a free trial

WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) FAQs

  • Where is WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) headquartered?

    WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) is headquartered in Wuxi, China.

  • What industry is WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) in?

    WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China)’s primary industry is Buildings and Property.

  • Is WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) a private or public company?

    WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) is a Private company.

  • What is WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China)’s current revenue?

    The current revenue for WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) is .

  • Who are WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China)’s investors?

    WuXi Biologics has invested in WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China).

  • When was WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) acquired?

    WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) was acquired on 06-Jan-2025.

  • Who acquired WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China)?

    WuXi Biologics (Preclinical Trispecific T-cell Engager in Wuxi, China) was acquired by Candid Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process